CA017094/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
1989	2
1990	1
1999	1
2005	2
2006	2
2007	4
2008	2
2009	8
2010	4
2011	6
2012	14
2013	4
2014	8
2015	3
2016	3
2024	0

1

Inhibitors of phosphatidylinositol-3-kinase in cancer therapy.

Ihle NT, Powis G. Ihle NT, et al. Mol Aspects Med. 2010 Apr;31(2):135-44. doi: 10.1016/j.mam.2010.02.003. Epub 2010 Feb 20. Mol Aspects Med. 2010. PMID: 20176047 Free PMC article. Review.

2

Interplay between the immune system and adipose tissue in obesity.

Exley MA, Hand L, O'Shea D, Lynch L. Exley MA, et al. J Endocrinol. 2014 Nov;223(2):R41-8. doi: 10.1530/JOE-13-0516. Epub 2014 Sep 16. J Endocrinol. 2014. PMID: 25228503 Review.

3

Synthesis, characterization, and anti-melanoma activity of tetra-O-substituted analogs of nordihydroguaiaretic acid.

Meyers RO, Lambert JD, Hajicek N, Pourpak A, Kalaitzis JA, Dorr RT. Meyers RO, et al. Bioorg Med Chem Lett. 2009 Aug 15;19(16):4752-5. doi: 10.1016/j.bmcl.2009.06.063. Epub 2009 Jun 21. Bioorg Med Chem Lett. 2009. PMID: 19615898 Free PMC article.

4

Take your PIK: phosphatidylinositol 3-kinase inhibitors race through the clinic and toward cancer therapy.

Ihle NT, Powis G. Ihle NT, et al. Mol Cancer Ther. 2009 Jan;8(1):1-9. doi: 10.1158/1535-7163.MCT-08-0801. Mol Cancer Ther. 2009. PMID: 19139107 Free PMC article. Review.

5

HAF : the new player in oxygen-independent HIF-1alpha degradation.

Koh MY, Powis G. Koh MY, et al. Cell Cycle. 2009 May 1;8(9):1359-66. doi: 10.4161/cc.8.9.8303. Cell Cycle. 2009. PMID: 19377289 Free PMC article. Review.

6

Targeting integrin α6 stimulates curative-type bone metastasis lesions in a xenograft model.

Landowski TH, Gard J, Pond E, Pond GD, Nagle RB, Geffre CP, Cress AE. Landowski TH, et al. Mol Cancer Ther. 2014 Jun;13(6):1558-66. doi: 10.1158/1535-7163.MCT-13-0962. Epub 2014 Apr 16. Mol Cancer Ther. 2014. PMID: 24739392 Free PMC article.

7

A phase IB trial of 24-hour intravenous PX-12, a thioredoxin-1 inhibitor, in patients with advanced gastrointestinal cancers.

Baker AF, Adab KN, Raghunand N, Chow H, Stratton SP, Squire SW, Boice M, Pestano LA, Kirkpatrick DL, Dragovich T. Baker AF, et al. Invest New Drugs. 2013 Jun;31(3):631-641. doi: 10.1007/s10637-012-9846-2. Epub 2012 Jun 19. Invest New Drugs. 2013. PMID: 22711542 Free PMC article. Clinical Trial.

8

Imexon induces an oxidative endoplasmic reticulum stress response in pancreatic cancer cells.

Sheveleva EV, Landowski TH, Samulitis BK, Bartholomeusz G, Powis G, Dorr RT. Sheveleva EV, et al. Mol Cancer Res. 2012 Mar;10(3):392-400. doi: 10.1158/1541-7786.MCR-11-0359. Epub 2012 Jan 24. Mol Cancer Res. 2012. PMID: 22275514 Free PMC article.

9

Reproducibility of magnetic resonance perfusion imaging.

Zhang X, Pagel MD, Baker AF, Gillies RJ. Zhang X, et al. PLoS One. 2014 Feb 25;9(2):e89797. doi: 10.1371/journal.pone.0089797. eCollection 2014. PLoS One. 2014. PMID: 24587040 Free PMC article.

10

IMPROVED SYNTHESIS OF 10-(2-ALKYLAMINO-2-OXOETHYL)-1,4,7,10-TETRAAZACYCLODODECANE-1,4,7-TRIACETIC ACID DERIVATIVES BEARING ACID-SENSITIVE LINKERS.

Jagadish B, Ozumerzifon TJ, Roberts SA, Hall GB, Mash EA, Raghunand N. Jagadish B, et al. Synth Commun. 2014;44(3):10.1080/00397911.2013.813547. doi: 10.1080/00397911.2013.813547. Synth Commun. 2014. PMID: 24363464 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

56 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

56 results

Results by year